91 related articles for article (PubMed ID: 3876506)
1. Anti-major histocompatibility complex immunity detected prior to intentional alloimmunization. I. Naturally occurring H-2-specific antibodies in C57BL/KaLwRij (H-2b) mice.
Cerný-Provaznik R; Radl J; van Mourik P; Leupers T; Brondijk R; de Greeve P; Iványi P
Nat Immun Cell Growth Regul; 1985; 4(3):138-59. PubMed ID: 3876506
[TBL] [Abstract][Full Text] [Related]
2. Anti-major histocompatibility complex immunity detected prior to intentional alloimmunization. II. Monoclonal H-2-specific antibodies obtained from an unimmunized C57BL/KaLwRij (H-2b) mouse.
Cerný-Provaznik R; van Mourik P; Radl J; Leupers T; Limpens JC; Iványi P
Nat Immun Cell Growth Regul; 1985; 4(3):160-8. PubMed ID: 4047072
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
4. Induction of H-2-specific antibodies by injections of syngeneic Sendai virus-coated cells.
Kievits F; Rocca A; Opolski A; Limpens J; Leupers T; Kloosterman T; Boerenkamp WJ; Pla M; Ivanyi P
Eur J Immunol; 1987 Jan; 17(1):27-35. PubMed ID: 3028822
[TBL] [Abstract][Full Text] [Related]
5. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
6. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
Hodes RJ; Shigeta M; Hathcock KS; Fathman CG; Singer A
J Immunol; 1982 Jul; 129(1):267-71. PubMed ID: 6177752
[TBL] [Abstract][Full Text] [Related]
7. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
8. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
9. The H-2 haplotype of a thymus graft influences the Ir gene regulated IgG3, IgG1, IgG2b, and IgG2a anti-(T,G)-A--L antibody responses of high-responder F1.nude mice.
Press JL; Haber J; Wortis HH
J Immunol; 1982 Jan; 128(1):441-6. PubMed ID: 6798113
[TBL] [Abstract][Full Text] [Related]
10. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
Matuszyk J; Zioło E; Kobzdej M; Strzadala L
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
[TBL] [Abstract][Full Text] [Related]
11. [Specificity of cell mediated cytotoxicity. I. Cytotoxic reactions in H-2 system after allogeneic sensitization in vivo].
Schulze HA; Brock J; Siegl E
Allerg Immunol (Leipz); 1982; 28(2):109-17. PubMed ID: 6182781
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
13. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
14. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
15. Genetics of natural antitumor antibody production: antibodies to MHC-linked determinants detected in the serum of unstimulated mice.
Wolosin LB; Greenberg AH
J Immunol; 1981 Apr; 126(4):1456-9. PubMed ID: 6162890
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
17. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
Peterson LB; Wilner GD; Thomas DW
J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
[TBL] [Abstract][Full Text] [Related]
18. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
Ozato K; Sachs DH
J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
[TBL] [Abstract][Full Text] [Related]
20. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
